M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Pharming receives UK NICE recommendation for Joenja to treat APDS in patients aged 12 and older
Biopharmaceutical company Pharming Group N.V. (Euronext Amsterdam:PHARM) (NASDAQ:PHAR) revealed on Wednesday that it has received a positive final recommendation from the National Institute for Health and Care Excellence (NICE) for Joenja (leniolisib) as a treatment for activated...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search